Identification and characterization of new impurity in Cefotaxime Sodium drug substance | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.


Identification and characterization of new impurity in Cefotaxime Sodium drug substance

Author(s): Vundavilli Jagadeesh Kumar, Peruri Badarinadh Gupta, K.S.R.Pavan Kumar, Korrapati V.V.Prasada Rao, S.John Prasanna, G.S.Siva Kumar, Hemant Kumar Sharma and K Mukkanti

Cefotaxime Sodium is a third generation cephalosporin drug substance. During the analysis of Cefotaxime Sodium in our lab, one unknown impurity was detected in gradient reverse phase High Performance Liquid Chromatography (HPLC) analysis at level ranging from 0.05 to 0.2% along with known impurities. This new impurity was detected by HPLC and have been identified by LCMS and was not reported in literature. The impurity was synthesized, isolated & characterized. Based on the spectral data, the impurity was named as, (6R,7R)-7-[(Z)-2-(2- amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-[[(2-benzothiazolyl)thio]methyl]-3-cephem- 4-carboxylic acid. The structure was established unambiguously by independent synthesis and co-injection in HPLC to confirm the retention time. Structural elucidation of this impurity by using spectral data (1H NMR, 13C NMR, MS and IR), synthesis, isolation, formation, validation and stability elucidation of this impurity has been discussed in detailed in this paper


Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank